Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Nova Eye Medical ( (AU:EYE) ) is now available.
Nova Eye Medical Limited reported a record full-year revenue of A$29.2 million for the fiscal year 2025, marking a 23% increase from the previous year. The company’s glaucoma segment showed significant improvement with a positive EBITDA in the second half of FY25. The company also reduced its cash outflow from operations and aims for breakeven EBITDA in the first half of FY26, indicating a positive trajectory in financial performance and operational efficiency.
More about Nova Eye Medical
Nova Eye Medical Limited is a medical technology company focused on developing advanced ophthalmic treatment technologies and devices.
Average Trading Volume: 466,877
Technical Sentiment Signal: Hold
Current Market Cap: A$42.62M
See more data about EYE stock on TipRanks’ Stock Analysis page.